Enterovirus infectious disease

This study looks at whether an inactivated enterovirus 71 (EV71) vaccine still protects children two to two-and-a-half years after the last dose. It involves 126 healthy children from Vietnam who received the vaccine in an earlier phase 3 trial. Researchers will take a blood samp…

Researchers are testing an inactivated enterovirus 71 (EV71) vaccine in healthy infants and children aged 2 months to 6 years. The trial aims to see if two shots of the vaccine can prevent hand, foot and mouth disease caused by EV71 and reduce severe complications like neurologic…

This study looked at how well an inactivated EV71 vaccine protects children over 5 years after vaccination. It included 180 healthy kids who were first vaccinated between 2 months and 6 years old. Researchers measured antibody levels to see if protection lasted. The goal was to u…

This study tested whether the drug vapendavir can reduce breathing problems in people with COPD who catch a rhinovirus (common cold). Fifty-two adults with COPD were given either vapendavir or a placebo after being exposed to the virus. The main goal was to see if vapendavir lowe…

This early-stage study tested the safety of a new drug called EV68-228-N in 36 healthy adults aged 18 to 49. Participants received a single dose of the drug or a placebo by IV, and were monitored for side effects for up to 29 days. The goal was not to treat any disease, but to ga…

This study looked at whether viral infections and diabetes in pregnant women are linked to congenital heart defects in their babies. Researchers analyzed blood and stool samples from 114 women to detect viruses and immune responses. The goal was to gather knowledge for future lar…